About the Authors
- Vivek Subbiah
-
* E-mail: vsubbiah@mdanderson.org
Affiliations Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas
- Aung Naing
-
Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas
- Robert E. Brown
-
Affiliation Department of Pathology and Laboratory Medicine, UT Health, University of Texas–Houston Medical School, Houston, Texas
- Helen Chen
-
Affiliation Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland
- Laurence Doyle
-
Affiliation Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland
- Patricia LoRusso
-
Affiliation Wayne State University–Barbara Ann Karmanos Cancer Institute, Detroit, Michigan
- Robert Benjamin
-
Affiliation Division of Cancer Medicine, Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
- Pete Anderson
-
Affiliation Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Razelle Kurzrock
-
Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: VS AN REB RK. Performed the experiments: VS AN REB RK. Analyzed the data: VS AN REB HC PA RK. Contributed reagents/materials/analysis tools: VS AN REB HC LD PL RB PA RK. Wrote the paper: VS REB RK.